Key result
Disruption of lipid rafts with MβCD or the actin cytoskeleton with cytochalasin D increased platelet sensitivity to PGI2 and forskolin, resulting in greater inhibition of platelet aggregation.
Population
Blood platelets
Comparison
Disruption of lipid rafts with… vs Untreated platelets
Design
Preclinical
Authors
Loading...
Should not yet influence antiplatelet therapy; extends basic understanding of cAMP compartmentalization in platelets.
Lipid rafts and the actin cytoskeleton play a key role in restraining basal cAMP signalling and regulating the inhibitory effects of prostacyclin in blood platelets.
Raslan et al. (2014) studied this question. Disruption of lipid rafts with methyl-beta-cyclodextrin (MβCD) or actin cytoskeleton with cytochalasin D was evaluated on Platelet sensitivity to PGI2 and forskolin (cAMP formation, PKA-mediated signalling, platelet aggregation). Disruption of lipid rafts with MβCD or the actin cytoskeleton with cytochalasin D increased platelet sensitivity to PGI2 and forskolin, resulting in greater inhibition of platelet aggregation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: